AJB Capital Investments Updates BIO-KEY Stake to 26,137 Shares

Ticker: BKYI · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1019034

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**AJB Capital Investments still holds 26,137 shares of BIO-KEY.**

AI Summary

AJB Capital Investments LLC, a Florida-based investment firm, filed an amended Schedule 13G on January 25, 2024, disclosing its beneficial ownership in BIO-KEY INTERNATIONAL, INC. As of December 31, 2023, AJB Capital Investments LLC holds sole voting and dispositive power over 26,137 shares of BIO-KEY's common stock. This filing is important for investors as it updates the public on a significant shareholder's position, indicating their continued, albeit small, interest in the company.

Why It Matters

This filing provides transparency on institutional ownership, showing that AJB Capital Investments LLC maintains a position in BIO-KEY INTERNATIONAL, INC., which can influence investor sentiment.

Risk Assessment

Risk Level: low — This is an amendment to a passive ownership filing, indicating no significant change in control or strategy, thus posing low risk.

Analyst Insight

Investors should note that a passive institutional investor like AJB Capital Investments LLC continues to hold a position in BIO-KEY, but this filing alone doesn't signal any immediate strategic changes or significant new investment, suggesting a 'hold' or 'monitor' approach.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of this SC 13G/A filing?

This SC 13G/A filing is an amendment (Amendment No. 1) to a Schedule 13G, indicating an update to previously disclosed beneficial ownership information for BIO-KEY INTERNATIONAL, INC. by AJB Capital Investments LLC, as required by the Securities Exchange Act of 1934.

Who is the reporting person in this filing?

The reporting person in this filing is AJB Capital Investments LLC, a company incorporated in the United States with a business address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021.

What is the CUSIP number for the securities reported?

The CUSIP number for the Common Stock, $0.0001 par value per share, of BIO-KEY INTERNATIONAL, INC. is 09060C507, as stated on the cover page of the filing.

As of what date is the beneficial ownership information reported?

The beneficial ownership information is reported as of December 31, 2023, which is identified as the 'Date of Event Which Requires Filing of this Statement'.

How many shares does AJB Capital Investments LLC have sole voting and dispositive power over?

AJB Capital Investments LLC has sole voting power over 26,137 shares and sole dispositive power over 26,137 shares of BIO-KEY INTERNATIONAL, INC. common stock, as detailed in items 5 and 8 of the filing.

Filing Stats: 1,371 words · 5 min read · ~5 pages · Grade level 10.6 · Accepted 2024-01-25 16:01:47

Key Financial Figures

Filing Documents

STATEMENT FILED PURSUANT TO RULE 13D-1(B)

ITEM 3. STATEMENT FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B) OR (C) Not applicable.

OWNERSHIP

ITEM 4. OWNERSHIP The information contained in Items 5-9 and 11 of the cover pages of this Schedule 13G is hereby incorporated by reference into this Item 4. AJB Capital Investments LLC (“AJB Investments”) is the direct Issuer’s Shares, and has the sole power to vote and dispose of such securities. - 4 - AJB Capital Managers LLC (“AJB Managers”), in its capacity as the Manager of AJB Investments, has the ability to direct the management of the business of AJB Investments including the power to vote and dispose of securities beneficially owned by AJB Investments; therefore, AJB Managers may be deemed to have indirect beneficial ownership of the Shares held by AJB Investments. AJB Managers is managed by a board of managers (the “Board of Managers”) which operates by majority vote such that no individual member of the Board of Managers has voting or dispositive control over the Shares. Each individual constituting the Board of Managers therefore expressly disclaims beneficial ownership of these securities. Pursuant to Rule 13d-4 of the Exchange Act, the Reporting Persons declare that filing this Schedule 13G shall not be construed as an admission that any such person is, for the purposes of Section 13(d) and/or Section 13(g) of the Exchange Act, the beneficial owner of any securities covered by this Schedule 13G except to the extent of such person’s pecuniary interest in the Units, and except to the extent of its pecuniary interest, such beneficial ownership is expressly disclaimed by each Reporting Person. All calculations of percentage ownership herein are based on 13,731,669 Shares outstanding as of November 17, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 20, 2023, which was

OWNERSHIP OF FIVE PERCENT OR LESS OF

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

OWNERSHIP OF MORE THAN FIVE PERCENT ON

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable.

IDENTIFICATION AND CLASSIFICATION OF

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON Not applicable.

IDENTIFICATION AND CLASSIFICATION OF

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. - 5 -

NOTICE OF DISSOLUTION OF GROUP

ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable.

CERTIFICATION

ITEM 10. CERTIFICATION. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: January 25, 2024 AJB CAPITAL INVESTMENTS LLC By: AJB Capital Managers LLC, its Manager By: /s/ Ari Blaine, Authorized Manager AJB CAPITAL MANAGERS LLC By: /s/ Ari Blaine, Authorized Manager INDEX TO EXHIBITS Exhibit 99.1 Joint Filing Agreement , incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons on January 10, 2023. - 6 -

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing